A detailed history of Brown Advisory Inc transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Brown Advisory Inc holds 6,573 shares of DGX stock, worth $901,092. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,573
Previous 6,480 1.44%
Holding current value
$901,092
Previous $886,000 1.69%
% of portfolio
0.0%
Previous 0.0%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$137.09 - $137.09 $12,749 - $12,749
93 Added 1.44%
6,573 $901,000
Q2 2024

Aug 14, 2024

BUY
$125.91 - $144.34 $41,676 - $47,776
331 Added 5.38%
6,480 $886,000
Q1 2024

Apr 24, 2024

SELL
$123.78 - $142.11 $34,658 - $39,790
-280 Reduced 4.36%
6,149 $818,000
Q4 2023

Feb 08, 2024

SELL
$120.62 - $141.12 $2,653 - $3,104
-22 Reduced 0.34%
6,429 $886,000
Q3 2023

Oct 24, 2023

SELL
$121.86 - $144.92 $48,378 - $57,533
-397 Reduced 5.8%
6,451 $786,000
Q2 2023

Jul 31, 2023

SELL
$130.56 - $146.84 $56,271 - $63,288
-431 Reduced 5.92%
6,848 $962,000
Q1 2023

May 08, 2023

BUY
$131.53 - $155.76 $94,438 - $111,835
718 Added 10.94%
7,279 $1.03 Million
Q4 2022

Feb 13, 2023

SELL
$123.31 - $157.26 $15,783 - $20,129
-128 Reduced 1.91%
6,561 $1.03 Million
Q3 2022

Nov 14, 2022

BUY
$121.77 - $141.1 $9,619 - $11,146
79 Added 1.2%
6,689 $821,000
Q2 2022

Nov 14, 2022

SELL
$127.07 - $145.39 $26,176 - $29,950
-206 Reduced 3.02%
6,610 $879,000
Q2 2022

Sep 13, 2022

BUY
$127.07 - $145.39 $231,267 - $264,609
1,820 Added 27.53%
8,430 $1.12 Million
Q2 2022

Aug 02, 2022

SELL
$127.07 - $145.39 $332,033 - $379,904
-2,613 Reduced 28.33%
6,610 $947,000
Q1 2022

Nov 14, 2022

SELL
$129.09 - $164.35 $208,351 - $265,260
-1,614 Reduced 19.15%
6,816 $933,000
Q1 2022

Sep 13, 2022

BUY
$129.09 - $164.35 $310,719 - $395,590
2,407 Added 35.31%
9,223 $1.26 Million
Q1 2022

May 09, 2022

SELL
$129.09 - $164.35 $126,895 - $161,556
-983 Reduced 12.6%
6,816 $994,000
Q4 2021

Jan 27, 2022

BUY
$140.36 - $173.01 $92,777 - $114,359
661 Added 9.26%
7,799 $1.35 Million
Q3 2021

Nov 12, 2021

SELL
$132.95 - $158.0 $15,156 - $18,012
-114 Reduced 1.57%
7,138 $1.04 Million
Q2 2021

Jul 29, 2021

BUY
$126.66 - $141.48 $113,234 - $126,483
894 Added 14.06%
7,252 $957,000
Q1 2021

May 14, 2021

SELL
$114.63 - $133.34 $38,171 - $44,402
-333 Reduced 4.98%
6,358 $816,000
Q4 2020

Feb 12, 2021

BUY
$112.7 - $128.05 $9,128 - $10,372
81 Added 1.23%
6,691 $798,000
Q3 2020

Nov 16, 2020

BUY
$107.05 - $130.01 $7,386 - $8,970
69 Added 1.05%
6,610 $757,000
Q2 2020

Aug 14, 2020

BUY
$73.34 - $122.61 $49,431 - $82,639
674 Added 11.49%
6,541 $746,000
Q1 2020

May 15, 2020

SELL
$75.14 - $115.68 $1,277 - $1,966
-17 Reduced 0.29%
5,867 $472,000
Q4 2019

Feb 14, 2020

SELL
$100.29 - $107.99 $71,005 - $76,456
-708 Reduced 10.74%
5,884 $629,000
Q3 2019

Nov 14, 2019

BUY
$97.85 - $107.42 $87,673 - $96,248
896 Added 15.73%
6,592 $705,000
Q2 2019

Aug 12, 2019

SELL
$85.18 - $101.94 $167,293 - $200,210
-1,964 Reduced 25.64%
5,696 $580,000
Q1 2019

May 15, 2019

SELL
$80.68 - $89.92 $1,694 - $1,888
-21 Reduced 0.27%
7,660 $689,000
Q4 2018

Feb 13, 2019

BUY
$79.75 - $108.38 $7,097 - $9,645
89 Added 1.17%
7,681 $640,000
Q3 2018

Nov 13, 2018

BUY
$105.42 - $114.99 $150,645 - $164,320
1,429 Added 23.19%
7,592 $819,000
Q2 2018

Aug 10, 2018

SELL
$97.35 - $113.14 $4,478 - $5,204
-46 Reduced 0.74%
6,163 $678,000
Q1 2018

Jun 28, 2018

BUY
$96.42 - $107.88 $63,444 - $70,985
658 Added 11.85%
6,209 $623,000
Q1 2018

May 14, 2018

SELL
$96.42 - $107.88 $95,070 - $106,369
-986 Reduced 15.08%
5,551 $557,000
Q4 2017

Feb 12, 2018

BUY
$90.86 - $100.24 $3,634 - $4,009
40 Added 0.62%
6,537 $644,000
Q3 2017

Nov 13, 2017

BUY
$91.96 - $108.35 $1,103 - $1,300
12 Added 0.19%
6,497 $609,000
Q2 2017

Aug 14, 2017

BUY
N/A
6,485
6,485 $720,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.